Bristol-Myers Squibb (BMY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Bristol-Myers Squibb

    NYSE: BMY · Real-Time Price · USD
    47.13
    0.44 (0.94%)
    At close: Sep 05, 2025, 3:59 PM
    47.00
    -0.29%
    After-hours: Sep 05, 2025, 07:56 PM EDT

    Bristol-Myers Squibb Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 10.35B 11.46B 9.12B 13.98B
    Short-Term Investments
    		 513M 816M 130M 3.24B
    Long-Term Investments
    		 2.51B 2.5B 2.19B 2.71B
    Other Long-Term Assets
    		 2.36B 1.43B 1.04B 1.66B
    Receivables
    		 14.42B 15.26B 13.94B 12.52B
    Inventory
    		 2.56B 2.66B 2.34B 2.1B
    Other Current Assets
    		 1.94B 1.56B 1.74B 1.43B
    Total Current Assets
    		 29.78B 31.77B 27.27B 33.26B
    Property-Plant & Equipment
    		 8.36B 8.04B 7.47B 6.97B
    Goodwill & Intangibles
    		 45.36B 48.65B 57.5B 63.28B
    Total Long-Term Assets
    		 62.82B 63.39B 69.55B 76.05B
    Total Assets
    		 92.6B 95.16B 96.82B 109.31B
    Account Payables
    		 3.6B 3.26B 3.04B 2.95B
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 2.05B 3.12B 4.26B 4.95B
    Other Current Liabilities
    		 14.6B 12.79B 11.99B 11.48B
    Total Current Liabilities
    		 23.77B 22.26B 21.89B 21.87B
    Long-Term Debt
    		 47.6B 36.65B 35.06B 39.6B
    Other Long-Term Liabilities
    		 2.87B 4.59B 5.05B 6.13B
    Total Long-Term Liabilities
    		 52.44B 43.41B 43.81B 51.44B
    Total Liabilities
    		 76.22B 65.67B 65.7B 73.31B
    Total Debt
    		 51.2B 41.46B 40.72B 45.6B
    Common Stock
    		 292M 292M 292M 292M
    Retained Earnings
    		 14.91B 28.77B 25.5B 23.82B
    Comprehensive Income
    		 -1.24B -1.55B -1.28B -1.27B
    Shareholders Equity
    		 16.34B 29.43B 31.06B 35.95B
    Total Investments
    		 3.02B 3.31B 2.32B 5.96B

    Add to Watchlist